SCHEMBL24309476

SCHEMBL24309476

CN(C)c1ccccc1-c1cc(Oc2ccccc2)nc(N[S+]([O-])c2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR39 O43194 1/20 0.41
▸ MAPT P10636 3/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ CYP2C19 P33261 3/20 0.36
▸ MAPK1 P28482 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NUDT1 P36639 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ HTT P42858 1/20 0.31
▸ GRM5 P41594 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309988 0.78 GPR39 (0.43) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL29567129 0.77 TSHR (0.48) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL24309475 0.77 TSHR (0.48) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL24309592 0.73 NPC1 (0.37) GPR39MAPTMAPK1NUDT1MEN1
SCHEMBL24310765 0.72 GPR39 (0.38) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL24309956 0.70 GPR39 (0.35) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL26810820 0.65 TSHR (0.49) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL24310492 0.61 TDP1 (0.44) MAPTTDP1TSHRMEN1KMT2A
SCHEMBL26810957 0.61 TSHR (0.54) GPR39MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL26810948 0.60 TSHR (0.55) GPR39TSHRNPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback